Anadys Pharmaceuticals, Inc.
3115 Merryfield Row
San Diego
California
92121
United States
Tel: 858-530-3600
Fax: 858-527-1540
Website: http://www.anadyspharma.com/
Email: corpinfo@anadyspharma.com
164 articles about Anadys Pharmaceuticals, Inc.
-
Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development
3/5/2018
Retrophin, Inc. (NASDAQ:RTRX) today announced that Casey Logan has joined the Company as vice president, corporate development.
-
Anadys Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results and Highlights
11/7/2011
-
Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc.
10/20/2011
-
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals, Inc. in Connection with the Sale of the Company to Roche Holding AG
10/17/2011
-
Roche Buys Anadys Pharmaceuticals, Inc. for $230 Million to Boost Hepatitis Ops
10/17/2011
-
Anadys Pharmaceuticals, Inc. Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study
10/13/2011
-
Anadys Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
9/16/2011
-
Anadys Pharmaceuticals, Inc.' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch
9/8/2011
-
Anadys Pharmaceuticals, Inc. Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
9/7/2011
-
Anadys Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
9/2/2011
-
Anadys Pharmaceuticals, Inc. Appoints Brian S. Posner to Its Board of Directors
8/23/2011
-
Anadys Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results and Highlights
8/9/2011
-
Anadys Pharmaceuticals, Inc. to Report Second Quarter 2011 Financial Results
8/2/2011
-
Anadys Pharmaceuticals, Inc. Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
6/2/2011
-
Anadys Pharmaceuticals, Inc. Highlights ANA773 Data to be Presented at American Society of Clinical Oncology
5/26/2011
-
Anadys Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results and Highlights
5/6/2011
-
Anadys Pharmaceuticals, Inc. to Report First Quarter 2011 Financial Results
5/3/2011
-
Anadys Pharmaceuticals, Inc. Appoints Barry Labinger to Its Board of Directors
3/16/2011
-
Anadys Pharmaceuticals, Inc. Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights
3/4/2011
-
Anadys Pharmaceuticals, Inc. to Present at the Cowen and Company Healthcare Conference
3/2/2011